Research and Development
Therapath’s scientific research program reflects our commitment to helping physicians provide the best possible care for their patients, by developing new technologies that more reliably diagnose neurological diseases.
A current focus of our research is the application of differential gene expression to the development of diagnostic tests for inflammatory diseases of the peripheral nerves. Patent applications #s 20060194237 and 20060194238.
Therapath has an interest in collaborating with medical centers to license or develop new technologies that advance our diagnostic capabilities in the field of peripheral neuropathy. Therapath will also consider proposals from investigators to provide pathological, molecular, or immunologic analysis of skin or nerve tissue samples for research, with IRB approval.
Inquiries regarding Therapath's licensing or research programs should be directed to Bruce Blake at BBlake@Therapath.com